Prednimustine

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 434002897 | IUPAC_name = (11β)-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl 4-{4-[bis(2-chloroethyl)amino]phenyl}butanoate | image = Prednimustine.png

| tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref =  ^Y | CAS_number = 29069-24-7 | ATC_prefix = L01 | ATC_suffix = AA08 | PubChem = 34457 | DrugBank_Ref =  ^Y | DrugBank = | UNII_Ref =  ^N | UNII = 9403SIO2S8 | KEGG_Ref =  ^Y | KEGG = C19512 | ChemSpiderID_Ref =  ^N | ChemSpiderID = 31708

| C=35 | H=45 | Cl=2 | N=1 | O=6 | molecular_weight = 646.64 g/mol | synonyms = [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate | smiles = C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CCCc4ccc(cc4)N(CCCl)CCCl)O)CCC5=CC(=O)C=C[C@]35C)O | InChI = 1/C35H45Cl2NO6/c1-33-14-12-26(39)20-24(33)8-11-27-28-13-15-35(43,34(28,2)21-29(40)32(27)33)30(41)22-44-31(42)5-3-4-23-6-9-25(10-7-23)38(18-16-36)19-17-37/h6-7,9-10,12,14,20,27-29,32,40,43H,3-5,8,11,13,15-19,21-22H2,1-2H3/t27-,28-,29-,32+,33-,34-,35-/m0/s1 | InChIKey = HFVNWDWLWUCIHC-GUPDPFMOBT | StdInChI_Ref =  ^N | StdInChI = 1S/C35H45Cl2NO6/c1-33-14-12-26(39)20-24(33)8-11-27-28-13-15-35(43,34(28,2)21-29(40)32(27)33)30(41)22-44-31(42)5-3-4-23-6-9-25(10-7-23)38(18-16-36)19-17-37/h6-7,9-10,12,14,20,27-29,32,40,43H,3-5,8,11,13,15-19,21-22H2,1-2H3/t27-,28-,29-,32+,33-,34-,35-/m0/s1 | StdInChIKey_Ref =  ^N | StdInChIKey = HFVNWDWLWUCIHC-GUPDPFMOSA-N }}

WikiDoc Resources for Prednimustine
Articles
Most recent articles on Prednimustine Most cited articles on Prednimustine Review articles on Prednimustine Articles on Prednimustine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Prednimustine Images of Prednimustine Photos of Prednimustine Podcasts & MP3s on Prednimustine Videos on Prednimustine
Evidence Based Medicine
Cochrane Collaboration on Prednimustine Bandolier on Prednimustine TRIP on Prednimustine
Clinical Trials
Ongoing Trials on Prednimustine at Clinical Trials.gov Trial results on Prednimustine Clinical Trials on Prednimustine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Prednimustine NICE Guidance on Prednimustine NHS PRODIGY Guidance FDA on Prednimustine CDC on Prednimustine
Books
Books on Prednimustine
News
Prednimustine in the news Be alerted to news on Prednimustine News trends on Prednimustine
Commentary
Blogs on Prednimustine
Definitions
Definitions of Prednimustine
Patient Resources / Community
Patient resources on Prednimustine Discussion groups on Prednimustine Patient Handouts on Prednimustine Directions to Hospitals Treating Prednimustine Risk calculators and risk factors for Prednimustine
Healthcare Provider Resources
Symptoms of Prednimustine Causes & Risk Factors for Prednimustine Diagnostic studies for Prednimustine Treatment of Prednimustine
Continuing Medical Education (CME)
CME Programs on Prednimustine
International
Prednimustine en Espanol Prednimustine en Francais
Business
Prednimustine in the Marketplace Patents on Prednimustine
Experimental / Informatics
List of terms related to Prednimustine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Prednimustine is a drug used in chemotherapy. It is the ester formed from two other drugs, prednisolone and chlorambucil.

It can be associated with myoclonus.